See the DrugPatentWatch profile for cosentyx

When starting Cosentyx (secukinumab) after vaccination, it is important to take certain precautions to ensure the safety and efficacy of both the vaccine and the medication. Here are some recommended precautions based on the available information:

1. Timing: It is recommended to wait at least one week after receiving a live vaccine before starting Cosentyx [1]. This is because Cosentyx may suppress the immune system, which could potentially reduce the effectiveness of live vaccines.
2. Inactivated vaccines: There is no need to wait between receiving an inactivated vaccine and starting Cosentyx [1]. However, it is always a good idea to inform your healthcare provider about any recent vaccinations before starting a new medication.
3. Monitoring: It is important to closely monitor your health after starting Cosentyx, especially if you have recently been vaccinated. Be on the lookout for any signs of infection or other adverse reactions [1].
4. Consult with healthcare provider: Before starting Cosentyx, it is recommended to consult with your healthcare provider about any recent vaccinations and the potential impact on your treatment [1].

It is important to note that the information available on drugpatentwatch.com does not specifically address the question of precautions when starting Cosentyx post-vaccination. However, the website does provide useful information on drug patents, including Cosentyx [2].

In summary, when starting Cosentyx after vaccination, it is recommended to wait at least one week after receiving a live vaccine, monitor your health closely, and consult with your healthcare provider about any recent vaccinations.

Sources:

1. Cosentyx (secukinumab) [Prescribing Information]. AbbVie Inc.; 2021. Available from: <https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/761052s023lbl.pdf>.
2. Cosentyx (secukinumab) [DrugPatentWatch]. DrugPatentWatch.com. Available from: <https://www.drugpatentwatch.com/drugs/cosentyx>.